Literature DB >> 25657078

Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla.

Bing Yao1,2, Vasiliki N Ikonomidou3,4, Fredric K Cantor3, Joan M Ohayon3, Jeff Duyn1, Francesca Bagnato3,5.   

Abstract

BACKGROUND AND
PURPOSE: Postmortem studies in multiple sclerosis (MS) indicate that in some white matter lesions (WM-Ls), iron is detectable with T2*-weighted (T2*-w), and its reciprocal R2* relaxation rate, magnetic resonance imaging (MRI) at 7.0 Tesla (7T). This iron appears as a hyperintense rim in R2* images surrounding a hypointense core. We describe how this observation relates to clinical/radiological characteristics of patients, in vivo.
METHODS: We imaged 16 MS patients using 3T and 7T scanners. WM-Ls were identified on T1-w / T2-w 3T-MRIs. Thereafter, WM-Ls with a rim of elevated R2* at 7T were counted and compared to their appearance on conventional MRIs.
RESULTS: We counted 36 WM-Ls presenting a rim of elevated R2* in 10 patients. Twenty-three (64%) lesions coincided with focal WM-Ls on T2-w MRIs; 13 (36%) coincided with only portions of larger lesions on T2-w images; and 20 (56%) corresponded to a hypointense chronic black hole. WM-Ls presenting a rim of elevated R2* were seen in both relapsing-remitting patients with low disability and in those with long-standing secondary progressive MS.
CONCLUSIONS: WM-Ls with a contour of high R2* are present at different MS stages, potentially representing differences in the contribution of iron in MS disease evolution.
Copyright © 2015 by the American Society of Neuroimaging.

Entities:  

Keywords:  7.0 tesla; Multiple sclerosis; T2*-weighted; iron; magnetic resonance imaging

Mesh:

Year:  2015        PMID: 25657078      PMCID: PMC5613291          DOI: 10.1111/jon.12193

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  31 in total

1.  Immunopathology of secondary-progressive multiple sclerosis.

Authors:  J W Prineas; E E Kwon; E S Cho; L R Sharer; M H Barnett; E L Oleszak; B Hoffman; B P Morgan
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

2.  Real-time shimming to compensate for respiration-induced B0 fluctuations.

Authors:  P van Gelderen; J A de Zwart; P Starewicz; R S Hinks; J H Duyn
Journal:  Magn Reson Med       Date:  2007-02       Impact factor: 4.668

3.  Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging.

Authors:  David Pitt; Aaron Boster; Wei Pei; Eric Wohleb; Adam Jasne; Cherian R Zachariah; Kottil Rammohan; Michael V Knopp; Petra Schmalbrock
Journal:  Arch Neurol       Date:  2010-07

4.  Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients.

Authors:  Michael J House; Timothy G St Pierre; Kris V Kowdley; Thomas Montine; James Connor; John Beard; Jose Berger; Narendra Siddaiah; Eric Shankland; Lee-Way Jin
Journal:  Magn Reson Med       Date:  2007-01       Impact factor: 4.668

5.  In vivo quantification of T₂ anisotropy in white matter fibers in marmoset monkeys.

Authors:  Pascal Sati; Afonso C Silva; Peter van Gelderen; Maria I Gaitan; Jillian E Wohler; Steven Jacobson; Jeff H Duyn; Daniel S Reich
Journal:  Neuroimage       Date:  2011-08-27       Impact factor: 6.556

6.  Serial magnetization transfer imaging to characterize the early evolution of new MS lesions.

Authors:  N C Silver; M Lai; M R Symms; G J Barker; W I McDonald; D H Miller
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

7.  Susceptibility contrast in high field MRI of human brain as a function of tissue iron content.

Authors:  Bing Yao; Tie-Qiang Li; Peter van Gelderen; Karin Shmueli; Jacco A de Zwart; Jeff H Duyn
Journal:  Neuroimage       Date:  2008-11-05       Impact factor: 6.556

8.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

9.  Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Authors:  Wolfgang J Streit; Heiko Braak; Qing-Shan Xue; Ingo Bechmann
Journal:  Acta Neuropathol       Date:  2009-06-10       Impact factor: 17.088

10.  Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Authors:  Veela Mehta; Wei Pei; Grant Yang; Suyang Li; Eashwar Swamy; Aaron Boster; Petra Schmalbrock; David Pitt
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  12 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Authors:  Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

3.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.

Authors:  S Zhang; T D Nguyen; S M Hurtado Rúa; U W Kaunzner; S Pandya; I Kovanlikaya; P Spincemaille; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-16       Impact factor: 3.825

4.  Smoldering lesions in MS: if you like it then you should put a rim on it.

Authors:  Catarina Pinto; Melissa Cambron; Adrienn Dobai; Eva Vanheule; Jan W Casselman
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

5.  Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression.

Authors:  Constantina A Treaba; Allegra Conti; Eric C Klawiter; Valeria T Barletta; Elena Herranz; Ambica Mehndiratta; Andrew W Russo; Jacob A Sloane; Revere P Kinkel; Nicola Toschi; Caterina Mainero
Journal:  Brain Commun       Date:  2021-06-24

Review 6.  Opportunities for Molecular Imaging in Multiple Sclerosis Management: Linking Probe to Treatment.

Authors:  Aline M Thomas; Frederik Barkhof; Jeff W M Bulte
Journal:  Radiology       Date:  2022-04-26       Impact factor: 29.146

7.  Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions.

Authors:  Y Yao; T D Nguyen; S Pandya; Y Zhang; S Hurtado Rúa; I Kovanlikaya; A Kuceyeski; Z Liu; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-14       Impact factor: 3.825

8.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Authors:  Assunta Dal-Bianco; Günther Grabner; Claudia Kronnerwetter; Michael Weber; Romana Höftberger; Thomas Berger; Eduard Auff; Fritz Leutmezer; Siegfried Trattnig; Hans Lassmann; Francesca Bagnato; Simon Hametner
Journal:  Acta Neuropathol       Date:  2016-10-27       Impact factor: 17.088

9.  Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET.

Authors:  Marjo Nylund; Marcus Sucksdorff; Markus Matilainen; Eero Polvinen; Jouni Tuisku; Laura Airas
Journal:  Brain Commun       Date:  2021-12-22

10.  Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.

Authors:  Nelly Blindenbacher; Eveline Brunner; Susanna Asseyer; Michael Scheel; Nadja Siebert; Ludwig Rasche; Judith Bellmann-Strobl; Alexander Brandt; Klemens Ruprecht; Dominik Meier; Jens Wuerfel; Friedemann Paul; Tim Sinnecker
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.